Unknown

Dataset Information

0

Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes.

ABSTRACT:

SUBMITTER: Ismail HM 

PROVIDER: S-EPMC8530714 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes.

Ismail Heba M HM  

The Journal of clinical endocrinology and metabolism 20211001 11

Similar Datasets

Unknown The Potential Causes of Cystic Fibrosis-Related Diabetes.
| S-EPMC8361832 | biostudies-literature
Unknown Drug treatments for managing cystic fibrosis-related diabetes.
| S-EPMC8094754 | biostudies-literature
Unknown Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
| S-EPMC2752940 | biostudies-literature
Unknown Cystic fibrosis autoantibody signatures associate with <i>Staphylococcus aureus</i> lung infection or cystic fibrosis-related diabetes.
| S-EPMC10519797 | biostudies-literature
Unknown Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach.
| S-EPMC6499442 | biostudies-literature
Unknown Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study.
| S-EPMC9826418 | biostudies-literature
Unknown Metabolomics Panel Associated with Cystic Fibrosis-Related Diabetes toward Biomarker Discovery.
| S-EPMC11292812 | biostudies-literature
Unknown Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
| S-EPMC5931120 | biostudies-literature
Unknown Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
| S-EPMC7236628 | biostudies-literature
Unknown Current Practices and Potential Nanotechnology Perspectives for Pain Related to Cystic Fibrosis.
| S-EPMC6678759 | biostudies-literature